Search

Your search keyword '"M. Witham"' showing total 71 results

Search Constraints

Start Over You searched for: Author "M. Witham" Remove constraint Author: "M. Witham"
71 results on '"M. Witham"'

Search Results

1. Long term health outcomes in people with diabetes 12 months after hospitalisation with COVID-19 in the UK: a prospective cohort studyResearch in context

2. Long-term impact of COVID-19 hospitalisation among individuals with pre-existing airway diseases in the UK: a multicentre, longitudinal cohort study – PHOSP-COVID

3. Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort studyResearch in context

4. Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study

5. The role of Braden scores in predicting outcomes following revascularisation for chronic limb-threatening ischaemia and their association with frailty

6. SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

7. 510 Co-design of an evidence and theory-based hospital deprescribing behaviour change intervention

8. Diverse Sphingolipid Species Harbor Different Effects on Ire1 Clustering

9. The conserved C-terminus of Sss1p is required to maintain the endoplasmic reticulum permeability barrier

10. Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls

11. The Interplay between Social and Ecological Determinants of Mental Health for Children and Youth in the Climate Crisis

12. Author response for 'Metformin and carotid intima media thickness in never smokers with type 1 diabetes: the REMOVAL trial'

13. Cancer associated mutations in Sec61γ alter the permeability of the ER translocase

14. Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial

15. Intracortical haematogenous osteomyelitis

16. Remarkable Rate Enhancement of Ligand Substitution Promoted by Geometrical Arrangement of Tridentate 'Spectator' Ligands

17. Congenital unilateral absence of sternocleidomastoid and trapezius muscles: a case report and literature review

18. Tris(2-pyridyl) tripod ligands1Dedicated to Daryle H. Busch on the occasion of his 70th birthday.1

19. ChemInform Abstract: Tris(2-pyridyl) Tripod Ligands

20. Aerobic oxidation of methyl p-tolyl sulfide catalyzed by a remarkably labile heteroscorpionate RuII-aqua complex, fac-[RuII(H2O)(dpp)(tppm)]2+

21. Remarkable Rate Enhancement of Ligand Substitution Promoted by Geometrical Arrangement of Tridentate 'Spectator' Ligands K.J.T. acknowledges Arco Chemical and the National Science Foundation for support of this research. M.H.V.H. gratefully acknowledges postdoctoral fellowship support from the Director's Office of Los Alamos National Laboratory. Los Alamos National Laboratory is operated by the University of California for the U.S. Department of Energy under Contract W-7405-ENG-36. M.H.V.H. also thanks Dr. Beverly K. Hartline (Deputy Laboratory Director, Argonne National Laboratory), Dr. Donald G. Lee (Chemistry Professor, University of Regina, Saskatchewan, Canada, S4S0A2), Dr. R. Thomas Baker (Los Alamos National Laboratory), and Dr. David E. Morris (Los Alamos National Laboratory) for their suggestions and discussions

22. Remarkable spectator ligand effect on the rate constant of ligand substitution of (aqua)ruthenium(II) complexes

23. Doctors are not pressured into giving prescriptions

24. Pharmacology

25. Remarkable Rate Enhancement of Ligand Substitution Promoted by Geometrical Arrangement of Tridentate 'Spectator' Ligands K.J.T. acknowledges Arco Chemical and the National Science Foundation for support of this research. M.H.V.H. gratefully acknowledges postdoctoral fellowship support from the Director's Office of Los Alamos National Laboratory. Los Alamos National Laboratory is operated by the University of California for the U.S. Department of Energy under Contract W-7405-ENG-36. M.H.V.H. also thanks Dr. Beverly K. Hartline (Deputy Laboratory Director, Argonne National Laboratory), Dr. Donald G. Lee (Chemistry Professor, University of Regina, Saskatchewan, Canada, S4S0A2), Dr. R. Thomas Baker (Los Alamos National Laboratory), and Dr. David E. Morris (Los Alamos National Laboratory) for their suggestions and discussions

28. Long COVID and cardiovascular disease: a prospective cohort study

29. Cancer associated mutations in Sec61γ alter the permeability of the ER translocase.

30. Impact of Age Differences in Chronic Limb-Threatening Ischemia Outcomes in Octogenarians.

31. The role of RAD51 regulators and variants in primary ovarian insufficiency, endometriosis, and polycystic ovary syndrome.

32. The lived experience of renal cachexia: An interpretive phenomenological analysis.

33. The human Shu complex promotes RAD51 activity by modulating RPA dynamics on ssDNA.

34. Sarcopenia and Sarcopenic Obesity on Body Composition Analysis is a Significant Predictor of Mortality in Severe Acute Pancreatitis: A Longitudinal Observational Study.

35. CompreHensive geriAtRician-led MEdication Review (CHARMER): protocol for a feasibility study of a hospital deprescribing behaviour change intervention.

36. Sarcopenia and sarcopenic obesity among community-dwelling Peruvian adults: A cross-sectional study.

37. Quality of life in advanced renal disease managed either by haemodialysis or conservative care in older patients.

38. Multimorbidity in bronchiectasis: a systematic scoping review.

39. Developing an Evidence and Theory Based Multimodal Integrative Intervention for the Management of Renal Cachexia: A Theory of Change.

40. Exploring the lived experience of renal cachexia for individuals with end-stage renal disease and the interrelated experience of their carers: Study protocol.

41. Multimorbidity and its socio-economic associations in community-dwelling older adults in rural Tanzania; a cross-sectional study.

42. MET-PREVENT: metformin to improve physical performance in older people with sarcopenia and physical prefrailty/frailty - protocol for a double-blind, randomised controlled proof-of-concept trial.

43. New horizons in evidence-based care for older people: individual participant data meta-analysis.

45. Using a generic definition of cachexia in patients with kidney disease receiving haemodialysis: a longitudinal (pilot) study.

46. Multimorbidity and mortality in an older, rural black South African population cohort with high prevalence of HIV findings from the HAALSI Study.

47. Prevalence and socio-demographic associations of diet and physical activity risk-factors for cardiovascular disease in Bo, Sierra Leone.

48. Erratum.

49. Depressive symptoms and cardiovascular disease: a population-based study of older adults in rural Burkina Faso.

50. Knowledge and understanding of cardiovascular disease risk factors in Sierra Leone: a qualitative study of patients' and community leaders' perceptions.

Catalog

Books, media, physical & digital resources